BamSEC and AlphaSense Join Forces
Learn More

PLUS THERAPEUTICS Inc.

NASDAQ: PSTV    
Share price (11/21/24): $1.20    
Market cap (11/21/24): $7.076 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.2
from 8-K 27 pages This Agreement Is Made on April 19, 2019 Parties Cytori Therapeutics, Inc. Duly Incorporated Under the Laws of Delaware of 3020 Callan Road, San Diego, Ca, 92121 (The "Seller") Seijirō Shirahama of 1-6-15 Hazawa, Nerima-Ku, Tokyo, 176-0003 Japan
12/34/56
EX-2.1
from 8-K 69 pages Asset and Equity Purchase Agreement by and Among Cytori Therapeutics, Inc. Cytori Therapeutics, K.K. (With Respect to Section 6.06 Only) and Lorem Vascular Pte. Ltd Dated as of March 29, 2019
12/34/56
EX-2.1
from 8-K 27 pages This Agreement Is Made on April 19, 2019 Parties Cytori Therapeutics, Inc. Duly Incorporated Under the Laws of Delaware of 3020 Callan Road, San Diego, Ca, 92121 (The "Seller") Seijirō Shirahama of 1-6-15 Hazawa, Nerima-Ku, Tokyo, 176-0003 Japan
12/34/56
EX-2.1
from 8-K 69 pages Asset and Equity Purchase Agreement by and Among Cytori Therapeutics, Inc. Cytori Therapeutics, K.K. (With Respect to Section 6.06 Only) and Lorem Vascular Pte. Ltd Dated as of March 29, 2019
12/34/56
EX-2.5
from 10-Q ~50 pages Asset Purchase Agreement
12/34/56
EX-2.1
from 8-K 5 pages Pro-Forma Financial Information
12/34/56
EX-2.1
from 8-K 53 pages Asset Purchase Agreement
12/34/56
EX-2.2
from 8-K 1 page Amendment No.1 to the Agreement and Plan of Reorganization
12/34/56
EX-2.1
from 8-K ~50 pages Agreement and Plan of Reorganization by and Among Macropore Biosurgery, Inc. Ms Acquisition, Inc. and Stemsource, Inc. Dated October 9, 2002
12/34/56
EX-2.4
from 8-K ~5 pages Amendment No. 2 to Development and Supply Agreement
12/34/56
EX-2.3
from 8-K ~10 pages Amended and Restated Distribution Agreement
12/34/56
EX-2.2
from 8-K ~10 pages License Agreement
12/34/56
EX-2.1
from 8-K ~20 pages Asset Purchase Agreement
12/34/56